Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric epithelial cells form the lining of the stomach mucosa, invaginating into gastric pits and glands. They include specialized subtypes such as surface mucous (foveolar) cells that secrete protective mucus, parietal cells that produce hydrochloric acid, chief cells that secrete pepsinogen, and neuroendocrine cells (e.g., G-cells, ECL cells) that regulate acid secretion via gastrin and histamine. These cells arise from multipotent stem cells in the isthmus region, undergo rapid renewal (2-3 days for surface cells), and coordinate digestion, barrier protection, and response to food presence. Not a specific therapeutic target like a receptor or enzyme; instead, a collective cell population implicated in gastric physiology and cancer[1][3][7][8][9][13].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric epithelial cell.